Kodiak Sciences Inc.
KOD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $27 | $26 | $11 | $9 |
| Gross Profit | -$27 | -$26 | -$11 | -$9 |
| % Margin | – | – | – | – |
| R&D Expenses | $126 | $206 | $268 | $217 |
| G&A Expenses | $0 | $71 | $0 | $0 |
| SG&A Expenses | $34 | $71 | $63 | $41 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$26 | $0 | $0 |
| Operating Expenses | $160 | $251 | $330 | $258 |
| Operating Income | -$187 | -$277 | -$341 | -$267 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $11 | $17 | $8 | $0 |
| Pre-Tax Income | -$176 | -$260 | -$334 | -$267 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$176 | -$260 | -$334 | -$267 |
| % Margin | – | – | – | – |
| EPS | -3.35 | -4.97 | -6.39 | -5.16 |
| % Growth | 32.6% | 22.2% | -23.8% | – |
| EPS Diluted | -3.35 | -4.97 | -6.39 | -5.16 |
| Weighted Avg Shares Out | 53 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 53 | 52 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $17 | $7 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $27 | $26 | $11 | $9 |
| EBITDA | -$150 | -$235 | -$323 | -$258 |
| % Margin | – | – | – | – |